Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

18,160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, Hyare H, Langbehn DR, Jones R, Leavitt BR, Roos RA, Durr A, Johnson H, Lehéricy S, Craufurd D, Kennard C, Hicks SL, Stout JC, Reilmann R, Tabrizi SJ; TRACK-HD investigators. Scahill RI, et al. Among authors: jones r. Hum Brain Mapp. 2013 Mar;34(3):519-29. doi: 10.1002/hbm.21449. Epub 2011 Nov 18. Hum Brain Mapp. 2013. PMID: 22102212 Free PMC article.
Visuomotor integration deficits precede clinical onset in Huntington's disease.
Say MJ, Jones R, Scahill RI, Dumas EM, Coleman A, Santos RC, Justo D, Campbell JC, Queller S, Shores EA, Tabrizi SJ, Stout JC; TRACK-HD Investigators. Say MJ, et al. Among authors: jones r. Neuropsychologia. 2011 Jan;49(2):264-70. doi: 10.1016/j.neuropsychologia.2010.11.016. Epub 2010 Nov 20. Neuropsychologia. 2011. PMID: 21094653
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC; TRACK-HD Investigators. Tabrizi SJ, et al. Among authors: jones r. Lancet Neurol. 2011 Jan;10(1):31-42. doi: 10.1016/S1474-4422(10)70276-3. Epub 2010 Dec 2. Lancet Neurol. 2011. PMID: 21130037
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR; TRACK-HD investigators. Tabrizi SJ, et al. Among authors: jones r. Lancet Neurol. 2012 Jan;11(1):42-53. doi: 10.1016/S1474-4422(11)70263-0. Epub 2011 Dec 2. Lancet Neurol. 2012. PMID: 22137354
Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.
Stout JC, Jones R, Labuschagne I, O'Regan AM, Say MJ, Dumas EM, Queller S, Justo D, Santos RD, Coleman A, Hart EP, Dürr A, Leavitt BR, Roos RA, Langbehn DR, Tabrizi SJ, Frost C. Stout JC, et al. Among authors: jones r. J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):687-94. doi: 10.1136/jnnp-2011-301940. Epub 2012 May 7. J Neurol Neurosurg Psychiatry. 2012. PMID: 22566599 Free PMC article.
Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease.
Labuschagne I, Jones R, Callaghan J, Whitehead D, Dumas EM, Say MJ, Hart EP, Justo D, Coleman A, Dar Santos RC, Frost C, Craufurd D, Tabrizi SJ, Stout JC; TRACK-HD Investigators. Labuschagne I, et al. Among authors: jones r. Psychiatry Res. 2013 May 15;207(1-2):118-26. doi: 10.1016/j.psychres.2012.09.022. Epub 2012 Oct 7. Psychiatry Res. 2013. PMID: 23051887
18,160 results
You have reached the last available page of results. Please see the User Guide for more information.